# Medviso AB

- Location (FDA's records): Lund, SE
- FDA decisions: 3 (2009–2022): 3 510(k) clearances
- Names in FDA's records: Medviso AB (2); Medviso (1)
- Product codes: LLZ (3)
- Predicates its devices cite: 7 (1 its own); citations of its devices by later devices: 4 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Medis Medical Imaging Systems BV: 2 (https://510kreport.com/company/medis-medical-imaging-systems)
- Diagnosoft, Inc.: 2 (https://510kreport.com/company/diagnosoft)
- Cardiovascular Imaging Solutions, Ltd.: 1 (https://510kreport.com/company/cardiovascular-imaging-solutions)
- Materialise NV: 1 (https://510kreport.com/company/materialise)

## Firms that cite its devices most
- Casis Cardiac Simulation & Imaging Software: 1 (https://510kreport.com/company/casis-cardiac-simulation-imaging-software)
- Pie Medical Imaging BV: 1 (https://510kreport.com/company/pie-medical-imaging)
- Omisa Inc. (Segasist Technologies): 1 (https://510kreport.com/company/omisa-segasist-technologies)

## Its most-cited devices
- K090833: Segment (2009), cited by 2
- K163076: Segment CMR (2017), cited by 2

## Recent decisions
- K211966: Segment 3DPrint (May 6, 2022)
- K163076: Segment CMR (Apr 5, 2017)
- K090833: Segment (May 12, 2009)

Source page: https://510kreport.com/company/medviso